/Investor DB

Sixty Degree Capital — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Everly Healtheverlywell.comin𝕏Series C · Apr 2020 · $50M

Everlywell offers at-home lab testing kits and virtual healthcare services across multiple wellness categories including daily health screening, digestive analysis, sexual health testing, and hormone monitoring.

ConsumerDigital HealthHealthtechWellness & Fitness

Julia Cheek(Founder & CEO)in

Co-investorsAnsa CapitalBreyer CapitalCerity Partners VenturesForesite CapitalHalogen Ventures Management Company LlcLux Capital+12 more

Kinaset Therapeuticskinasettherapeutics.comin𝕏Jul 2020

Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.

BiotechHealthtechMedfield, US

Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)

BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)

Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesGimvVivo Capital+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.